Company Filing History:
Years Active: 2015-2023
Title: Innovations and Achievements of Fahad Ibrahim Al-Jenoobi
Introduction
Fahad Ibrahim Al-Jenoobi, based in Riyadh, Saudi Arabia, is a prominent inventor recognized for his significant contributions to the field of pharmaceuticals. With an impressive portfolio comprising 21 patents, Al-Jenoobi is at the forefront of innovations aimed at enhancing healthcare outcomes.
Latest Patents
Among his latest inventions is a groundbreaking method for preventing, treating, or ameliorating microbial infections. This method includes the administration of thymoquinone, a compound that proves beneficial against infections caused by gram-negative bacteria, gram-positive bacteria, and fungi. It specifically addresses the challenges posed by antimicrobial-sensitive and antimicrobial-resistant strains.
Another noteworthy patent is the method of preparing low-dose pharmaceutical formulations. Al-Jenoobi’s approach facilitates the creation of solid unit dosage forms that deliver consistent low doses of various pharmaceuticals with minimal additives. This innovation is crucial for ensuring content uniformity across the prepared solid unit dosage forms.
Career Highlights
Fahad Ibrahim Al-Jenoobi is affiliated with King Saud University, an institution known for its focus on research and development in science and technology. His ongoing research and inventions underscore his commitment to advancing pharmaceutical sciences and improving patient care.
Collaborations
Al-Jenoobi collaborates with esteemed colleagues, including Mohd Aftab Alam and Abdullah M Al-Mohizea. Their joint efforts contribute to innovative research, fostering an environment rich in expertise and creativity.
Conclusion
Fahad Ibrahim Al-Jenoobi’s contributions to the pharmaceutical industry through his patents illustrate the vital role of innovation in healthcare. His work not only addresses pressing medical challenges but also sets a benchmark for future inventions in the field. As he continues to advance his research, Al-Jenoobi remains a key figure in the pursuit of innovative solutions for microbial infections and pharmaceutical formulations.